SPTB
Basic information
Region (hg38): 14:64746283-64879907
Links
Phenotypes
GenCC
Source:
- hereditary spherocytosis type 2 (Strong), mode of inheritance: AD
- hereditary spherocytosis (Supportive), mode of inheritance: AD
- hereditary elliptocytosis (Supportive), mode of inheritance: AD
- elliptocytosis 3 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spherocytosis, type 2; Ellipsocytosis 3 | AD/AR | Hematologic | Some individuals may have severe, transfusion-requiring anemia, and splenectomy may also be beneficial | Hematologic | 4426130; 7229027; 7119110; 7104494; 4052329; 3276733; 2807277; 2346784; 2070088; 1391962; 8102379; 8226774; 7883966; 8675627; 8844207; 9075575; 9005995; 9163587; 9414314; 9450796; 9609518; 9887280; 11703334; 19538529 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (82 variants)
- Hereditary spherocytosis type 2 (42 variants)
- SPTB-related disorder (6 variants)
- not specified (3 variants)
- Hemolytic anemia (1 variants)
- Hereditary spherocytosis (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPTB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 88 | 13 | 109 | |||
missense | 367 | 20 | 397 | |||
nonsense | 60 | 62 | 122 | |||
start loss | 2 | |||||
frameshift | 50 | 67 | 117 | |||
inframe indel | 9 | |||||
splice donor/acceptor (+/-2bp) | 11 | 24 | 35 | |||
splice region | 1 | 23 | 16 | 2 | 42 | |
non coding | 13 | 19 | 36 | 68 | ||
Total | 122 | 161 | 398 | 127 | 51 |
Variants in SPTB
This is a list of pathogenic ClinVar variants found in the SPTB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-64749356-C-T | Uncertain significance (Dec 28, 2023) | |||
14-64749368-C-T | Inborn genetic diseases • Hereditary spherocytosis type 2 | Uncertain significance (Sep 26, 2023) | ||
14-64749402-C-T | not specified | Benign (Nov 22, 2023) | ||
14-64749413-G-C | Inborn genetic diseases | Uncertain significance (Aug 17, 2021) | ||
14-64749427-T-G | Inborn genetic diseases | Uncertain significance (May 08, 2023) | ||
14-64749428-C-T | Uncertain significance (Jan 06, 2020) | |||
14-64749447-G-A | SPTB-related disorder | Benign (May 01, 2020) | ||
14-64749462-C-T | SPTB-related disorder | Likely benign (Sep 20, 2021) | ||
14-64749480-G-A | Uncertain significance (Nov 30, 2020) | |||
14-64749638-G-C | Likely benign (Mar 31, 2022) | |||
14-64749997-GCTT-G | Conflicting classifications of pathogenicity (Dec 20, 2023) | |||
14-64750000-T-G | Inborn genetic diseases | Uncertain significance (Apr 07, 2023) | ||
14-64750020-G-A | Familial hemolytic anemia | Uncertain significance (Feb 27, 2018) | ||
14-64750023-A-G | Inborn genetic diseases | Uncertain significance (Mar 21, 2023) | ||
14-64750030-A-AGAT | Uncertain significance (Aug 18, 2023) | |||
14-64750041-C-T | not specified | Uncertain significance (Mar 22, 2024) | ||
14-64750051-G-T | Familial hemolytic anemia | Uncertain significance (Feb 27, 2018) | ||
14-64750130-C-G | Uncertain significance (Nov 09, 2023) | |||
14-64753574-G-A | Inborn genetic diseases | Uncertain significance (Feb 01, 2023) | ||
14-64753580-G-A | Inborn genetic diseases | Uncertain significance (Jan 18, 2022) | ||
14-64753597-A-C | Inborn genetic diseases | Uncertain significance (Jan 24, 2024) | ||
14-64753601-GCA-G | Hereditary spherocytosis type 2 | Pathogenic (Mar 01, 2022) | ||
14-64753621-C-G | Inborn genetic diseases • SPTB-related disorder | Conflicting classifications of pathogenicity (Apr 10, 2023) | ||
14-64753621-C-T | Inborn genetic diseases | Uncertain significance (Jan 24, 2023) | ||
14-64753625-G-A | Inborn genetic diseases | Uncertain significance (Mar 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPTB | protein_coding | protein_coding | ENST00000389722 | 35 | 133600 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 2.95e-12 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.751 | 1278 | 1.36e+3 | 0.943 | 0.0000939 | 15320 |
Missense in Polyphen | 426 | 501.12 | 0.8501 | 5895 | ||
Synonymous | -2.28 | 657 | 587 | 1.12 | 0.0000414 | 4464 |
Loss of Function | 9.03 | 9 | 112 | 0.0802 | 0.00000574 | 1250 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000148 | 0.000148 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00153 | 0.00147 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000708 | 0.0000703 |
Middle Eastern | 0.00153 | 0.00147 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Spectrin is the major constituent of the cytoskeletal network underlying the erythrocyte plasma membrane. It associates with band 4.1 and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane.;
- Disease
- DISEASE: Elliptocytosis 3 (EL3) [MIM:617948]: A Rhesus-unlinked form of hereditary elliptocytosis, a genetically heterogeneous hematologic disorder characterized by variable hemolytic anemia and elliptical or oval red cell shape. Inheritance can be autosomal dominant or autosomal recessive. {ECO:0000269|PubMed:1975598, ECO:0000269|PubMed:7883966, ECO:0000269|PubMed:8018926, ECO:0000269|PubMed:8226774}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spherocytosis 2 (SPH2) [MIM:616649]: An autosomal dominant form of hereditary spherocytosis, a group of hematologic disorders characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. Clinical manifestations include chronic hemolytic anemia, jaundice, and splenomegaly, with variable severity. {ECO:0000269|PubMed:19538529, ECO:0000269|PubMed:8102379}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Developmental Biology;Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Interaction between L1 and Ankyrins;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;NCAM signaling for neurite out-growth;L1CAM interactions;COPI-mediated anterograde transport;Axon guidance;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.330
Intolerance Scores
- loftool
- 0.144
- rvis_EVS
- -2.64
- rvis_percentile_EVS
- 0.78
Haploinsufficiency Scores
- pHI
- 0.313
- hipred
- Y
- hipred_score
- 0.793
- ghis
- 0.557
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.853
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Sptb
- Phenotype
- reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; renal/urinary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- sptb
- Affected structure
- nucleate erythrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- teardrop-shaped
Gene ontology
- Biological process
- MAPK cascade;endoplasmic reticulum to Golgi vesicle-mediated transport;cytoskeleton organization;axon guidance;actin filament capping
- Cellular component
- Golgi apparatus;cytosol;spectrin;spectrin-associated cytoskeleton;actin cytoskeleton;intrinsic component of the cytoplasmic side of the plasma membrane;protein-containing complex
- Molecular function
- actin binding;Ras guanyl-nucleotide exchange factor activity;structural constituent of cytoskeleton;protein binding;ankyrin binding;actin filament binding